Dra. M. José Ribal: “We are working to treat all urological diseases in Europe in the same way”
Interview with Dr. M. José Ribal, Head of the Urological Onocology Unit. Dra. Ribal has been appointed the new president of the Office of Clinical Gu1
Interview with Dr. M. José Ribal, Head of the Urological Onocology Unit. Dra. Ribal has been appointed the new president of the Office of Clinical Gu1
Along with prostate cancer, erectile dysfunction is one of the most common reasons for consultations in urology and, as such, is one of the matters t1
Dialysis patients began to be vaccinated against COVID-19 in February 2021. However, there were many doubts about whether immunisation would be effec1
Researchers from the Hospital Clínic-IDIBAPS coordinated a study that made it possible to determine with an accuracy of 96% whether a kidney transpla1
A study published by the American Journal of Transplantation and led by researchers from the Hospital Clínic-IDIBAPS states that 65% of all patients1
The Hospital Clínic de Barcelona has become the first hospital in Spain to carry out over 1,000 living donor kidney transplants. To mark this milesto1
The majority of kidney donors believe that it was worth going through the process of donation, and would repeat it if necessary. This study, coor1
In a retrospective study with 80 kidney transplant patients with COVID-19, treatment with tocilizumab demonstrates a decrease in one of the inflammat1
In recent years, much research has been carried out to find an alternative treatment for erectile dysfunction, other than traditional drug therapy. O1
For patients with chronic kidney disease, potassium is an important nutrient that needs to be controlled to prevent potential adverse effects. This m1